| # | Title | Journal | Year | Citations |
|---|
| 1 | Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome | Gastroenterology | 2017 | 542 |
| 2 | Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome | Alimentary Pharmacology and Therapeutics | 2018 | 423 |
| 3 | Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis | Gut | 2018 | 397 |
| 4 | Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis | Gut | 2015 | 360 |
| 5 | Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease | Alimentary Pharmacology and Therapeutics | 2017 | 285 |
| 6 | Chronic constipation | Nature Reviews Disease Primers | 2017 | 203 |
| 7 | Systematic review with meta‐analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea | Alimentary Pharmacology and Therapeutics | 2015 | 155 |
| 8 | Systematic review with meta‐analysis: malignancies with anti‐tumour necrosis factor‐α therapy in inflammatory bowel disease | Alimentary Pharmacology and Therapeutics | 2014 | 144 |
| 9 | Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis | Gut | 2017 | 137 |
| 10 | Systematic review with meta‐analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease | Alimentary Pharmacology and Therapeutics | 2016 | 136 |
| 11 | The overlap of atopy and functional gastrointestinal disorders among 23 471 patients in primary care | Alimentary Pharmacology and Therapeutics | 2014 | 97 |
| 12 | Characteristics of functional bowel disorder patients: a cross‐sectional survey using the Rome III criteria | Alimentary Pharmacology and Therapeutics | 2014 | 87 |
| 13 | Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating | Alimentary Pharmacology and Therapeutics | 2015 | 70 |
| 14 | Systematic review with meta‐analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers | Alimentary Pharmacology and Therapeutics | 2015 | 69 |
| 15 | Systematic review and meta‐analysis: opportunistic infections and malignancies during treatment with anti‐integrin antibodies in inflammatory bowel disease | Alimentary Pharmacology and Therapeutics | 2015 | 68 |
| 16 | Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic | Frontline Gastroenterology | 2014 | 64 |
| 17 | Systematic review with meta‐analysis: the effect of tobacco smoking on the natural history of ulcerative colitis | Alimentary Pharmacology and Therapeutics | 2016 | 56 |
| 18 | Systematic review and network meta‐analysis: efficacy of drugs for functional dyspepsia | Alimentary Pharmacology and Therapeutics | 2021 | 53 |
| 19 | Cyclic vomiting syndrome is a prevalent and under‐recognized condition in the gastroenterology outpatient clinic | Neurogastroenterology and Motility | 2018 | 37 |
| 20 | The relationship between different information sources and disease‐related patient knowledge and anxiety in patients with inflammatory bowel disease | Alimentary Pharmacology and Therapeutics | 2017 | 36 |
| 21 | Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease | Inflammatory Bowel Diseases | 2019 | 36 |
| 22 | Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: case–control study of 23 471 primary care patients | Alimentary Pharmacology and Therapeutics | 2014 | 30 |
| 23 | Systematic review with meta‐analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria | Alimentary Pharmacology and Therapeutics | 2020 | 29 |
| 24 | Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation | Neurogastroenterology and Motility | 2021 | 25 |
| 25 | Managing inflammatory bowel disease in pregnancy: current perspectives | Clinical and Experimental Gastroenterology | 2016 | 22 |
| 26 | Dyspepsia | Current Opinion in Gastroenterology | 2013 | 18 |
| 27 | No increase in prevalence of somatization in functional vs organic dyspepsia: a cross‐sectional survey | Neurogastroenterology and Motility | 2015 | 18 |
| 28 | Cyclic vomiting syndrome: a case series and review of the literature | Frontline Gastroenterology | 2018 | 17 |
| 29 | Irritable Bowel Syndrome-Type Symptoms Are Associated With Psychological Comorbidity, Reduced Quality of Life, and Health Care Use in Patients With Inflammatory Bowel Disease | Gastroenterology | 2017 | 14 |
| 30 | Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care | Alimentary Pharmacology and Therapeutics | 2017 | 11 |
| 31 | Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis | Alimentary Pharmacology and Therapeutics | 2017 | 10 |
| 32 | Commentary: estimating the prevalence of IBS globally—past, present and future | Alimentary Pharmacology and Therapeutics | 2020 | 7 |
| 33 | Peppermint Oil in Irritable Bowel Syndrome | Gastroenterology | 2020 | 7 |
| 34 | Symbiotics in irritable bowel syndrome – better than probiotics alone? | Current Opinion in Clinical Nutrition and Metabolic Care | 2015 | 6 |
| 35 | A Bidirectional Relationship Between Symptom Reporting and Perceived Stress, But Not Disease Activity, in Inflammatory Bowel Disease: More Questions Than Answers? | Gastroenterology | 2017 | 6 |
| 36 | Letter: causes of fatigue in inflammatory bowel disease remain uncertain | Alimentary Pharmacology and Therapeutics | 2017 | 4 |
| 37 | Use of Probiotics in Hospitalized Adults to Prevent Clostridium difficile Infection: DownGRADE the Quality of Evidence? | Gastroenterology | 2017 | 3 |
| 38 | Multiple myeloma presenting in association with gastric phytobezoar | Clinical Case Reports (discontinued) | 2017 | 3 |
| 39 | Healthy Mind, Healthy Body: Chronic Depression May Predate the Development of Inflammatory Bowel Disease by up to 9 Years | Gastroenterology | 2021 | 3 |
| 40 | Letter: bile acid diarrhoea is not a rare cause of diarrhoea in secondary care | Alimentary Pharmacology and Therapeutics | 2014 | 2 |
| 41 | Irritable bowel syndrome and somatization | Neurogastroenterology and Motility | 2015 | 2 |
| 42 | Combining Biomarkers in Irritable Bowel Syndrome: A Forward Step Toward Making a Positive Diagnosis and Directing Therapy? | Gastroenterology | 2015 | 2 |
| 43 | Defining the Relationship Between Clinical and Biochemical Disease Activity Indices and Perceived Stress in Inflammatory Bowel Disease | Gastroenterology | 2015 | 2 |
| 44 | Depression Is Associated With Subjective Measures of Crohn's Disease Activity During Longitudinal Follow-up | Gastroenterology | 2016 | 2 |
| 45 | Editorial: subgroups in irritable bowel syndrome—more than just diarrhoea and constipation? | Alimentary Pharmacology and Therapeutics | 2017 | 2 |
| 46 | Probiotics for Treating Irritable Bowel Syndrome: Are Bugs the Best Drugs? | Gastroenterology | 2018 | 2 |
| 47 | Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care | Gastroenterology | 2019 | 2 |
| 48 | Editorial: minesapride for irritable bowel syndrome with constipation | Alimentary Pharmacology and Therapeutics | 2020 | 2 |
| 49 | Letter: effects of iron therapy after non-variceal acute upper gastrointestinal bleeding | Alimentary Pharmacology and Therapeutics | 2014 | 1 |
| 50 | The Fall and Rise of 5-Hydroxytryptamine Receptor Antagonists in Irritable Bowel Syndrome With Diarrhea | Gastroenterology | 2014 | 1 |
